Skip to main content

Andrew Brackin


Andrew is a Partner at Gradient Ventures.

Prior to Gradient, Andrew co-founded Vial, a tech-enabled clinical trial platform that raised over $100M in venture capital from top-tier firms. Prior to Vial, he was part of the founding team and the Head of Growth at Newfront (YC W18), an AI-powered commercial insurance brokerage valued at $2.2BN, insuring numerous Fortune 500 companies. His career began at Jobr, a mobile job search business that acquired in 2016.

Andrew was a 2013 recipient of the Thiel Fellowship. Outside of work, he loves reading about global affairs, working out at Barry’s Bootcamp, and enjoying live music.

Investments include

  • Forge leverages AI to simplify procurement management for hardware companies.

Gradient Ventures updates delivered straight to your inbox

Sign up to receive newsletters from Gradient Ventures. Your information will be used in accordance with Google's privacy policy. You may opt out at any time.
There was an error.
Thank you, we'll be in touch.